Kiniksa Pharmaceuticals International (KNSA) Other Gross PP&E Adjustments (2021 - 2025)
Kiniksa Pharmaceuticals International's Other Gross PP&E Adjustments history spans 5 years, with the latest figure at -$14.0 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 21.64% year-over-year to -$14.0 million; the TTM value through Dec 2025 reached -$14.0 million, up 21.64%, while the annual FY2025 figure was -$14.0 million, 21.64% up from the prior year.
- Other Gross PP&E Adjustments reached -$14.0 million in Q4 2025 per KNSA's latest filing, down from -$4.9 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.6 million in Q3 2021 to a low of -$19.1 million in Q4 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$7.0 million, with a median of -$6.9 million recorded in 2023.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 90.97% in 2023, then tumbled 1309.33% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$6.3 million in 2021, then plummeted by 37.57% to -$8.7 million in 2022, then crashed by 120.1% to -$19.1 million in 2023, then increased by 6.49% to -$17.8 million in 2024, then grew by 21.64% to -$14.0 million in 2025.
- Per Business Quant, the three most recent readings for KNSA's Other Gross PP&E Adjustments are -$14.0 million (Q4 2025), -$4.9 million (Q3 2025), and -$7.0 million (Q2 2025).